title: Risk-benefit assessment in management of adult idiopathic thrombocytopenic purpura.
authors.forename: Shojiro
authors.initials: S
authors.lastname: Takagi
authors.forename: Norio
authors.initials: N
authors.lastname: Komatsu
mesh_terms: D000305:Adrenal Cortex Hormones / Q000008:administration & dosage* / Q000009:adverse effects; D000818:Animals; D001161:Arteriosclerosis / Q000209:etiology; D002318:Cardiovascular Diseases / Q000139:chemically induced; D003920:Diabetes Mellitus / Q000139:chemically induced; D006801:Humans; D006976:Hypertension, Pulmonary / Q000209:etiology; D051379:Mice; D010024:Osteoporosis / Q000139:chemically induced; D010817:Physician-Patient Relations; D011239:Prednisolone / Q000008:administration & dosage / Q000009:adverse effects; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000628:therapy*; D051381:Rats; D018570:Risk Assessment; D013156:Splenectomy / Q000009:adverse effects; D013923:Thromboembolism / Q000209:etiology
chemical_list: D000305:Adrenal Cortex Hormones; D011239:Prednisolone